We are live on ! Find out more
Geode Capital Management

Geode Capital Management Portfolio holdings

AUM $1.61T
1-Year Est. Return 30.72%
 

Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.

This Fund
S&P 500
This Quarter Est. Return
+13.1%
1 Year Est. Return
+30.72%
3 Year Est. Return
+105.46%
5 Year Est. Return
+141.95%
10 Year Est. Return
+549.41%
AUM
$1.08T
AUM Growth
+$125B
Cap. Flow
+$32.6B
Cap. Flow %
3.01%
Top 10 Hldgs %
27.52%
Holding
4,738
New
85
Increased
3,720
Reduced
276
Closed
123

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$1.81B
2
MSFT icon
Microsoft
MSFT
+$1.34B
3
AAPL icon
Apple
AAPL
+$1.25B
4
AMZN icon
Amazon
AMZN
+$1.17B
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$480M

Sector Composition

Rank Sector Weight
1 Technology 29.47%
2 Financials 12.91%
3 Healthcare 12.22%
4 Consumer Discretionary 10.6%
5 Industrials 9.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RPT
4726
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
-477,650
Closed -$6.29M
TBLT
4727
DELISTED
ToughBuilt Industries, Inc. Common Stock
TBLT
-2,383
Closed -$25.6K
CANO
4728
DELISTED
Cano Health, Inc.
CANO
-50,680
Closed -$298K
HARP
4729
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
-149,262
Closed -$1.7M
ARVL
4730
DELISTED
Arrival Ordinary Shares
ARVL
-18,751
Closed -$21.2K
AGRX
4731
DELISTED
Agile Therapeutics
AGRX
-13,748
Closed -$26.8K
EAR
4732
DELISTED
Eargo, Inc. Common Stock
EAR
-47,221
Closed -$122K
PBLA
4733
DELISTED
Panbela Therapeutics, Inc. Common Stock
PBLA
-794
Closed -$14.5K
NVIV
4734
DELISTED
InVivo Therapeutics Holdings Corp
NVIV
-18,677
Closed -$13.6K
DISH
4735
DELISTED
DISH Network Corp.
DISH
-2,570,878
Closed -$14.6M
TIO
4736
DELISTED
Tingo Group, Inc. Common Stock
TIO
-2,722,396
Closed -$1.88M
DOC
4737
DELISTED
PHYSICIANS REALTY TRUST
DOC
-5,790,536
Closed -$77.1M
INTZ
4738
DELISTED
INTRUSION INC NEW
INTZ
-83,623
Closed -$21.2K

Similar funds

Geode Capital Management's Q1 2024 Portfolio in Review

As of Q1 2024, Geode Capital Management held 4,738 positions worth $1.08T, up 13% from $956B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Geode Capital Management deployed $32.6B of net new capital in Q1 2024, opening 85 new positions and adding to 3,720 existing holdings. Its largest new stake was Solventum: 2,733,775 shares worth $0.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 29% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Amgen, an estimated $204M trimmed.

  • Geode Capital Management's largest Q1 2024 buy was Solventum: 2,733,775 shares worth $0.
  • Geode Capital Management added most to NVIDIA in Q1 2024, an estimated $1.81B increase.
  • Geode Capital Management's biggest Q1 2024 reduction was Amgen, cutting an estimated $204M.
  • Geode Capital Management fully exited Splunk Inc in Q1 2024, selling an estimated $373M.
  • Geode Capital Management's ten largest holdings make up 28% of its $1.08T portfolio in Q1 2024.
  • Geode Capital Management opened 85 new positions and closed 123 in Q1 2024.
  • Geode Capital Management's portfolio value rose 13% quarter-over-quarter to $1.08T.

Based on Geode Capital Management's 13F filing for Q1 2024, filed 13 May 2024.